Data-driven Site Negotiations: Fast Track to Fair Market Value (FMV)

With investigator payments constituting as much as 50 percent of a study’s overall costs, it’s important to understand and manage the key drivers of these costs. By doing so, sponsors and CROs can benefit from accelerated negotiations, reduced compliance risk and better site relationships.

Join us for this one-hour webinar session to hear:

• A description of the primary drivers of site costs, with examples;
• An in-depth discussion of the correlation and impact of study complexity; and
• Case studies highlighting the benefits of better study planning.

Speakers

Stella Stergiopoulos, Project Manager, Tufts Center of the Study of Drug Developtment (CSDD)

Stella is a project director at Tuft’s Center for the Study of Drug Development. She has been with CSDD for approximately 5 years and recently co-authored on article in the American Journal of Therapeutics entitled, “Quantifying the Magnitude and Cost of Collecting Extraneous Protocol Data”.

Message Presenter

Vic DeSario, Director, Trial Planning Solutions, Medidata Solutions

Vic is Director of Trial Planning Solutions at Medidata. In this role he interacts with clinical trial sponsors, helping them optimize their clinical spending and related processes. He has been in the life sciences industry for 13 years preceded by another 15 in healthcare.

Message Presenter